drchrono

DrChrono was founded in New York City in 2009 by Daniel Kivatinos and Michael Nusimow. The company spent time in the Rose Tech Ventures incubator in New York City before moving to Silicon Valley to join Y Combinator. Nusimow, a computer engineer, created the program with the intention of streamlining patient-doctor visits. In February 2011, DrChrono launched as an EHR app for the iPad, allowing doctors to complete tasks and access information without needing to use paper records. The information gathered and accessed through the app is also available from a web browser, iOS and Android devices, on Google Glass, and the Apple Watch.

In June 2011, the company released the first tablet EHR system to be certified for meaningful use by Infogard Laboratories. Doctors who used their EHR app to store and track patient data received up to $44,000 in incentives from federal subsidies. In August 2012, DrChrono released OnPatient, an iOS and Android app to replace and expedite the traditional handwritten patient check-in process. It integrates with DrChrono's medical records interface.

As of December 2018, over $3 billion in medical claims are processed annually through the platform, and 13.2 million patients are under the care of DrChrono providers.

In January 2020, the company raised $20 million in a growth capital round from ORIX Growth Capital, a subsidiary of Orix USA, to invest further in the technology platform (EHR, medical billing, and API) and expand engineering, sales, and support functions.

DrChrono

DrChrono is an electronic health record (EHR) platform using open-source technologies like Linux, Python, MySQL, and Django, built on Apple's iOS. It offers an API for developers to create physician and patient apps. Doctors can manage appointments, records, prescriptions, and labs through customizable interfaces. Paid subscriptions include dictation and billing services. Patients access their records and appointments via iOS, watchOS, and Android apps. The service integrates with Acronis for file exchange and Apollo-plus for revenue cycle management. DrChrono pioneered the first health record system app for Google Glass and integrated with Apple Watch. It was the initial EHR to achieve Electronic Prescriptions for Controlled Substances (EPCS) certification and ONC certification for Meaningful Use Stage 3, enabling data sharing with other certified EHRs.

OnPatient

OnPatient is a patient-focused app providing health management tools, allowing data import from Google Health. Enables appointment reminders and secure communication with healthcare providers. It is available on Android/iOS.

On November 2, 2021, EverCommerce Inc., a publicly traded vertical SaaS company, announced a definitive agreement to acquire DrChrono. The acquisition closed on November 18, 2021. Although financial terms were not disclosed in the initial announcement, the deal was reported at approximately $180 million.

At the time of acquisition, DrChrono served more than 4,600 independent medical practices and 13,000 providers across multiple specialties. Following the acquisition, DrChrono joined EverCommerce's EverHealth solutions group and the platform was rebranded as DrChrono by EverHealth.